118 filings
Page 6 of 6
8-K
2gssd9069
5 Aug 15
MacroGenics Provides Update on Corporate Progress and 2014 Financial Results
12:00am
8-K
d2j265h0fc xlwj
30 Jul 15
MGD011 Advances into Clinical Development
12:00am
8-K
3b73txfl
15 Jul 15
MacroGenics Announces Proposed Public Offering of Common Stock
12:00am
8-K
geibi5d k5
22 May 15
Submission of Matters to a Vote of Security Holders
12:00am
8-K
pjg4dmcxeh
6 May 15
Results of Operations and Financial Condition
12:00am
8-K
e4rinb8 n924sot8d0ji
3 Mar 15
MacroGenics Provides Update on Corporate Progress and 2014 Financial Results
12:00am
8-K
nthz8
27 Jan 15
MacroGenics Announces Closing of Collaboration and License Agreement with Janssen to Develop MGD011 for Multiple B-Cell Malignancies
12:00am
8-K
9e1ifd6
22 Dec 14
MacroGenics Enters Collaboration and License Agreement with Janssen to Develop MGD011 for Multiple B-Cell Malignancies
12:00am
8-K
at197 bepyboexf9qwob
12 Nov 14
MacroGenics Provides Update on Corporate Progress and Third Quarter 2014 Financial Results
12:00am
8-K
qoo7c g2d
5 Aug 14
Results of Operations and Financial Condition
12:00am
8-K
7uhy b61j6m7i20c3
25 Jul 14
Other Events
12:00am
8-K
fpvt5
11 Jun 14
Submission of Matters to a Vote of Security Holders
12:00am
8-K
6f0i3d pt
29 May 14
MacroGenics and Takeda Enter Strategic Alliance to Develop
12:00am
8-K
42paqso2y0rkzbfxj60u
6 May 14
Results of Operations and Financial Condition
12:00am
8-K
xkmylppypulv5 98
20 Mar 14
MacroGenics Provides Update on Corporate Progress and 2013 Financial Results
12:00am
8-K
xa0gw
7 Mar 14
Departure of Directors or Certain Officers
12:00am
8-K
ldz6ktr bafu
12 Nov 13
MacroGenics Provides Corporate Progress Update and Third Quarter 2013 Financial Results
12:00am
8-K
bk66dsqkfvppsd
18 Oct 13
MacroGenics Announces Closing of Initial Public Offering and Full-Exercise of Over-Allotment Option
12:00am